Lipoid pneumonia and Mycobacterium fortuitum pulmonary infection: successful treatment with sulfisoxazole
Dixon, C.; Bolivar, R.; Katz, R.; McMurtrey, M.
Texas Medicine 81(3): 57-60
1985
ISSN/ISBN: 0040-4470 PMID: 3983869 Document Number: 4308
The rapidly growing mycobacteria are uncommon pathogens. Of the species included in this group, only Mycobacterium fortuitum and Mycobacterium cheloni have been shown to be pathogenic for man. Mycobacterium fortuitum has been increasingly recognized as a pathogen. It has been reported as an agent in infections of bone, endocardium, cornea, lung, skin, and soft tissue. Pulmonary infection is usually associated with achalasia, ankylosing spondylitis, and lipoid pneumonia (1-3). Treatment of pulmonary disease with surgery and various antituberculous drugs has not been consistently successful. Recently, pulmonary infections due to M cheloni, have been treated successfully with drugs such as amikacin, erythromycin, and sulfonamide (2-4). This report concerns one patient with lipoid pneumonia and M fortuitum pulmonary infection treated successfully with sulfisoxazole alone.
Document emailed within 1 workday
